Safety and Immunogenicity of an Adjuvanted <i>Clostridioides difficile</i> Vaccine Candidate in Healthy Adults: A Randomized Placebo-Controlled Phase 1 Study

Authors

Axel Lambert
Azhar Alhatemi
Charlotte Servais
Isabel Leroux‐Roels (ORCID: https://orcid.org/0000-0002-5084-4696)
Juan Pablo Yarzábal (ORCID: https://orcid.org/0000-0002-6490-2084)
Guilherme da Silva Ferreira (ORCID: https://orcid.org/0000-0001-7125-441X)
Fien De Boever
Bertrand de Wergifosse
Bart Jacobs (ORCID: https://orcid.org/0009-0000-9129-016X)
Magalie Caubet (ORCID: https://orcid.org/0000-0002-6760-7427)
Sandra Morel
Mohamed El Idrissi (ORCID: https://orcid.org/0000-0002-3306-3062)

Institutions

Ghent University Hospital (BE)
GlaxoSmithKline (Belgium) (BE)
GlaxoSmithKline (Switzerland) (CH)

Publication Details

Journal: The Journal of Infectious Diseases
Published: 2024-10-24
DOI: https://doi.org/10.1093/infdis/jiae466
Citations: 4
Primary Topic: Clostridium difficile and Clostridium perfringens research
Type: article
Field-Weighted Citation Impact: 1.56

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Safety and Immunogenicity of an Adjuvanted Clostridioides difficile Vaccine Candidate in Healthy Adults: A Randomized Placebo-Controlled Phase 1 Study

Axel Lambert, Azhar Alhatemi, Charlotte Servais, Isabel Leroux‐Roels et al.

Oct 24, 2024

4 citations

The Journal of Infectious Diseases

Clostridium difficile and Clostridium perfringens research

1.56

article

Safety and Immunogenicity of an Adjuvanted Clostridioides difficile Vaccine Candidate in Healthy Adults: A Randomized Placebo-Controlled Phase 1 Study

Axel Lambert, Azhar Alhatemi, Charlotte Servais, Isabel Leroux‐Roels, Juan Pablo Yarzábal, Guilherme da Silva Ferreira, Fien De Boever, Bertrand de Wergifosse, Bart Jacobs, Magalie Caubet, Sandra Morel, Mohamed El Idrissi

October 24, 2024article en

4 citations

Abstract

No abstract available for this paper.

The Journal of Infectious DiseasesVol. 231(3)

Ghent University Hospital (BE), GlaxoSmithKline (Belgium) (BE), GlaxoSmithKline (Switzerland) (CH)

Good health and well-being

Openalex Percentile: Top 17%

Clostridium difficile and Clostridium perfringens research

1.56

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.